Once Daily Aminoglycoside Therapy: Is It Less Toxic Than Multiple Daily Doses and How Should It Be Monitored?

Author： Barclay M.L. Kirkpatrick C.M.J. Begg E.J.

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.36, Iss.2, 1999-02, pp. : 89-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

How should patients with dyslipidaemia be monitored?

Inpharma, Vol. 1, Iss. 1652, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Once- Versus Twice-Daily Tacrolimus: Are the Formulations Truly Equivalent?

By Barraclough Katherine A.

Drugs, Vol. 71, Iss. 12, 2011-08 ,pp. : 1561-1577

Adis International

Access to resources Recommend Favorite

What Is the Best Strategy for Converting from Twice-Daily Divalproex to a Once-Daily Divalproex ER Regimen?: Examinations and Answers via Computer Simulations

By Ronald C. Reed Sandeep Dutta

Clinical Drug Investigation, Vol. 24, Iss. 9, 2004-01 ,pp. : 509-521

Adis International

Access to resources Recommend Favorite

Should the Currently Recommended Twice-Daily Dosing Still be Considered the Most Appropriate Regimen for Treating MRSA Ventilator-Associated Pneumonia with Vancomycin?

By Pea Federico

Clinical Pharmacokinetics, Vol. 47, Iss. 3, 2008-01 ,pp. : 147-152

Adis International

Access to resources Recommend Favorite

Drospirenone: less safe than other hormonal contraceptives?

Reactions Weekly, Vol. 1, Iss. 1427, 2012-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite